Unique Biomarkers Are Associated With More Drug Approvals

In our Chart of the Week post from last week we presented an analysis of the number of unique biomarkers being used by leading drug developers in their clinical trials (unique biomarkers being defined as those that aren’t being used by any other companies). This...

10 Diagnostics Innovators: Smaller Companies Are Leading the Way

As we have previously reported in this blog, innovation is not a major focus for many of the largest diagnostics companies.  With but a few exceptions, the focus for the largest companies tends to be on selling instrumentation and on developing “me-too” tests, which...

Huge Growth in New Biomarkers During 2014

The number of publications that describe studies involving new biomarkers increased significantly during 2014, with 37% more such studies in 2014 than 2013. This figure shows the total number of publications each year that include the words “novel...

There Has Been a Surge in New Biomarkers During 2014

There has been a significant surge in the number of new biomarkers described in the literature during 2014. Between 2008 and 2013, the annual growth rate in publications that describe new biomarkers was 25% per year. When looking at the average number of publications...

Who will fund the next generation of diagnostic tests?

More from Bruce Booth with a realistic (and pessimistic) perspective on diagnostic investments and related challenges. Key question: “…how does one generate a return from early stage diagnostic investing – the translation of academia-derived insights into...